The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C†
Abstract
UNLABELLED: Diabetes is present in patients with chronic hepatitis C virus infection. The aim of this retrospective cohort study was to assess the cumulative development incidence and predictive factors for type 2 diabetes after the termination of interferon therapy in Japanese patients positive for hepatitis C virus (HCV). A total of 2,842 HCV-positive patients treated with interferon (IFN) monotherapy or combination therapy with IFN and ribavirin were enrolled. The mean observation period was 6.4 years. An overnight (12-hour) fasting blood sample or a casual blood sample was taken for routine analyses during follow-up. The primary goal was the onset of type 2 diabetes. Evaluation was performed by using the Kaplan-Meier method and Cox proportional hazard analysis. Of 2,842 HCV patients, 143 patients developed type 2 diabetes. The cumulative development rate of type 2 diabetes was 3.6% at 5 years, 8.0% at 10 years, and 17.0% at 15 years. Multivariate Cox proportional hazard analysis revealed that type 2 diabetes development after the termination of IFN therapy occurred when histological staging was advanced (hazard ratio 3.30; 95% confidence interval [CI] 2.06-5.28; P < 0.001), sustained virological response was not achieved (hazard ratio 2.73; 95% CI 1.77-4.20; P < 0.001), the patient had pre-diabetes (hazard ratio 2.19; 95% CI 1.43-3.37; P < 0.001), and age was >or=50 years (hazard ratio 2.10; 95% CI 1.38-3.18; P < 0.001). CONCLUSION: Our results indicate sustained virological response causes a two-thirds reduction in the risk of type 2 diabetes development in HCV-positive patients treated with IFN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Classification and Diagnosis of Diabetes
Fajans, S. S. (1990) · Medical Entomology and Zoology · Cited by 2,356
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282501 · Cited by 1,126
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 879
Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.056 · Cited by 763
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Del Ninno, E., Dioguardi, N., Kuo, G., Donato, M. F., Tommasini, M. A., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Ikeda, K. (1993) · Hepatology · doi:10.1016/0270-9139(93)90505-h · Cited by 620
Self-citationLowering the Criterion for Impaired Fasting Glucose Is in Order
Genuth, S. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3331 · Cited by 559
Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., Kumada, H., & Kawanishi, M. (1993) · Hepatology · doi:10.1002/hep.1840180109 · Cited by 538
Self-citationHepatitis C Virus Infection and Incident Type 2 Diabetes
Mehta, S. H., Brancati, F. L., Strathdee, S. A., Pankow, J. S., Netski, D., Coresh, J., Szklo, M., & Thomas, D. L. (2003) · Hepatology · doi:10.1053/jhep.2003.50291 · Cited by 404
Designs for group sequential tests
Fleming, T. R., Harrington, D. P., & O'Brien, P. C. (1984) · Controlled Clinical Trials · doi:10.1016/s0197-2456(84)80014-8 · Cited by 353
Extrahepatic Immunologic Manifestations in Chronic Hepatitis C and Hepatitis C Virus Serotypes
Pawlotsky, J.-M., Roudot-Thoraval, F., Simmonds, P., Mellor, J., Yahia, M. B., Andre, C., Voisin, M.-C., Intrator, L., Zafrani, E.-S., Duval, J., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-3-199502010-00002 · Cited by 321
Veldt, B. J., Chen, W., Heathcote, J. E., Wedemeyer, H., Reichen, J., Hofmann, P. W., de Knegt, R. J., Zeuzem, S., Manns, M. P., Hansen, B. E., et al. (2008) · Hepatology · doi:10.1002/hep.22251 · Cited by 284
glycyrrhizin as a potential treatment for chronic hepatitis C
Rossum, T. G. J. V., Vulto, Man, R. A. D., Brouwer, & Schalm (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00309.x · Cited by 270
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
Kew, M. C., Houghton, M., Choo, Q. L., & Kuo, G. (1990) · The Lancet · doi:10.1016/0140-6736(90)90474-j · Cited by 253
Hepatitis C-associated hepatocellular carcinoma
Hasan, F., Jeffers, L. J., De Medina, M., Reddy, R. K., Parker, T., Schiff, E. R., Houghton, M., Choo, Q., & Kuo, G. (1990) · Hepatology · doi:10.1002/hep.1840120323 · Cited by 235
Romero-Gómez, M., Fernández-Rodríguez, C. M., Andrade, R. J., Diago, M., Alonso, S., Planas, R., Solá, R., Pons, J. A., Salmerón, J., Barcena, R., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.022 · Cited by 185
Waki, K., Noda, M., Sasaki, S., Matsumura, Y., Takahashi, Y., Isogawa, A., Ohashi, Y., Kadowaki, T., Tsugane, S., & for the JPHC Study Group (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01403.x · Cited by 170
Insulin resistance and hepatitis C
Romero‐Gómez, M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i44.7075 · Cited by 151
Simó, R., Lecube, A., Genescà, J., Esteban, J. I., & Hernández, C. (2006) · Diabetes Care · doi:10.2337/dc06-0456 · Cited by 119
Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis
Fabris, P., Betterle, C., Greggio, N. A., Zanchetta, R., Bosi, E., Biasin, M. R., & de Lalla, F. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80328-0 · Cited by 112
Imazeki, F., Yokosuka, O., Fukai, K., Kanda, T., Kojima, H., & Saisho, H. (2008) · Liver International · doi:10.1111/j.1478-3231.2007.01630.x · Cited by 111
Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus
Arao, M., Murase, K., Kusakabe, A., Yoshioka, K., Fukuzawa, Y., Ishikawa, T., Tagaya, T., Yamanouchi, K., Ichimiya, H., Sameshima, Y., et al. (2003) · Journal of Gastroenterology · doi:10.1007/s005350300063 · Cited by 94
Association between hepatitis C, diabetes mellitus, and race a case-control study
Thuluvath, P. J., & John, P. R. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07256.x · Cited by 88
Perspective: The Search for Genes for Type 2 Diabetes in the Post-Genome Era
Elbein, S. C. (2002) · Endocrinology · doi:10.1210/endo.143.6.8831 · Cited by 62
Cesare, E. D., Previti, M., Russo, F. P., Brancatelli, S., Ingemi, M. C., Scoglio, R., Mazzù, N., Cucinotta, D., & Raimondo, G. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02087923 · Cited by 51
Cited by
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
Negro, F., Forton, D., Craxì, A., Sulkowski, M. S., Feld, J. J., & Manns, M. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.035 · Cited by 361
Hsu, Y.-C., Lin, J.-T., Ho, H. J., Kao, Y.-H., Huang, Y.-T., Hsiao, N.-W., Wu, M.-S., Liu, Y.-Y., & Wu, C.-Y. (2014) · Hepatology · doi:10.1002/hep.26892 · Cited by 277
Pearlman, B. L., & Traub, N. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir076 · Cited by 261
Simmons, B., Saleem, J., Heath, K., Cooke, G. S., & Hill, A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ396 · Cited by 261
Metadata
- Authors
- Arase, Y., Suzuki, F., Suzuki, Y., Akuta, N., Kobayashi, M., Kawamura, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Hirakawa, M., Ikeda, K., & Kumada, H.
- Venue
- Hepatology
- Published
- 2009-03
- Volume
- 49
- Issue
- 3
- Pages
- 739-744
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2019598977
- Cited by
- 265
- References
- 34
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.